Researchers have mapped how lung damage begins early in life for children with cystic fibrosis, providing new insights that will help reshape future care. The research team, led by Murdoch Children's ...

Most of Dedra’s life was spent on the sidelines. She was diagnosed with cystic fibrosis – an inherited condition that causes mucus buildup in the lungs, and often leads to infections and damage to ...

In patients with cystic fibrosis (CF), the occurrence of pulmonary exacerbations requiring intensive therapy (PERITs) was associated with marked decline in lung function that was not always reversed ...

The development of gene editing tools, which enable the specific targeting and correction of mutations, hold the promise of allowing us to correct those mutations that cause genetic diseases. However, ...

A newly discovered mechanism renders antibiotic-resistant bacteria vulnerable by disabling both their individual resistance and a process known as cross-protection, the ability of resistant bacteria ...

People with CF may undergo multiple medical procedures to manage lung infections, digestive issues, and other complications. Cystic fibrosis (CF) is a genetic condition that leads to the production of ...

Cystic Fibrosis (CF) is a rare, genetic disease that damages the lungs, pancreas, and other vital organs, making it hard to ...

The transplant of two new lungs, a kidney and a liver into a single patient over 36 hours “continues to be at the edge of ...

Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) is a combination medicine approved by the FDA in 2024. Alyftrek is approved to treat people ages 6 and older who have ...

Cystic fibrosis is a rare, genetic disease that affects the lungs, pancreas, and other vital organs, requiring lifelong specialized care for the approximately 40,000 people living with it in the ...

Over the past three decades, meaningful progress has been made in the research and understanding of cystic fibrosis (CF). 1 While thousands of patients were able to benefit from t ...

Researchers have mapped how lung damage begins early in life for children with cystic fibrosis, providing new insights that will help reshape future care.